Articles

Nanogels as novel drug nanocarriers for CNS drug delivery

in Nanobiotechnology

• V. Manimaran
• R. P. Nivetha
• T. Tamilanban
• J. Narayanan
• Subramaniyan Vetriselvan
• Neeraj Kumar Fuloria
• Suresh V. Chinni
• Mahendran Sekar
• Shivkanya Fuloria
• Ling Shing Wong

Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery

in Individual and Social Behaviors

• Adam Michael Stewart
• Robert Gerlai
• Allan V. Kalueff

Editorial: Women in CNS drug delivery: 2022–2024

in <mark class="highlighted">CNS Drug</mark> Delivery

• Szilvia Veszelka
• Malgorzata Burek
• Sarah Ann Thomas

Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece

in Medicinal and Pharmaceutical Chemistry

• Bill W. G. L. Chan
• Nicholas B. Lynch
• Wendy Tran
• Jack M. Joyce
• G. Paul Savage
• Wim Meutermans
• Andrew P. Montgomery
• Michael Kassiou

Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior

in Psychopharmacology

• Tyra Lagerberg
• Arvid Sjölander
• Robert D. Gibbons
• Patrick D. Quinn
• Brian M. D’Onofrio
• Clara Hellner
• Paul Lichtenstein
• Seena Fazel
• Zheng Chang

Genetic Association of Phosphodiesterases With Human Cognitive Performance

in Molecular Signalling and Pathways

• Mark E. Gurney

Genetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice

• Susana Mingote
• Justine Masson
• Celia Gellman
• Gretchen M. Thomsen
• Chyuan-Sheng Lin
• Robert J. Merker
• Inna Gaisler-Salomon
• Yvonne Wang
• Rachel Ernst
• René Hen

Effects of Nicotine Exposure From Tobacco Products and Electronic Cigarettes on the Pathogenesis of Neurological Diseases: Impact on CNS Drug Delivery

in <mark class="highlighted">CNS Drug</mark> Delivery

• Sejal Sharma
• Sabrina Rahman Archie
• Vrajesh Kanchanwala
• Kyle Mimun
• Md Ashrafur Rahman
• Yong Zhang
• Thomas Abbruscato

Tranylcypromine Causes Neurotoxicity and Represses BHC110/LSD1 in Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids Model

in Neuropharmacology

• Jing Huang
• Fangkun Liu
• Hui Tang
• Haishan Wu
• Lehua Li
• Renrong Wu
• Jingping Zhao
• Ying Wu
• Zhixiong Liu
• Jindong Chen

Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish

in Experimental Pharmacology and Drug Discovery

• Giancarlo Bruni
• Parth Lakhani
• David Kokel

Induction of P-glycoprotein overexpression in brain endothelial cells as a model to study blood-brain barrier efflux transport

in <mark class="highlighted">CNS Drug</mark> Delivery

• Sarah F. Hathcock
• Hallie E. Knight
• Emma G. Tong
• Alexandra E. Meyer
• Henry D. Mauser
• Nadine Vollmuth
• Brandon J. Kim

Calcium Imaging in Drug Discovery for Psychiatric Disorders

in Schizophrenia

• Saurav Seshadri
• Daniel J. Hoeppner
• Katsunori Tajinda

LncRNA-driven programmed cell death networks: new therapeutic targets for neurological disorders

in Molecular Signalling and Pathways

• Zihong Xiong
• Chao Sun
• Shiyong Huang

Editorial: Environmental risk factors in autism spectrum disorder

in Autism

• Hideo Matsuzaki
• Kohji Fukunaga

Neurotherapeutics across blood–brain barrier: screening of BBB-permeable and CNS-active molecules for neurodegenerative disease

in Experimental Pharmacology and Drug Discovery

• D. Mohan Kumar
• Priti Talwar

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

in Neuropharmacology

• Knut Biber
• Anindya Bhattacharya
• Brian M. Campbell
• Justin R. Piro
• Michael Rohe
• Roland G.W. Staal
• Robert V. Talanian
• Thomas Möller